Process engineering of natural killer cell-based immunotherapy.

Motallebnejad, Pedram; Kantardjieff, Anne; Cichocki, Frank; Azarin, Samira M; Hu, Wei-Shou

Motallebnejad, Pedram; Kantardjieff, Anne; Cichocki, Frank; Azarin, Samira M; Hu, Wei-Shou.

Afiliación

Motallebnejad P; Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455, USA.
Kantardjieff A; Bluebird Bio, Cambridge, MA 02142, USA.
Cichocki F; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Azarin SM; Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455, USA.
Hu WS; Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: wshu@umn.edu.

Trends Biotechnol ; 41(10): 1314-1326, 2023 10.

Article en En | MEDLINE | ID: mdl-37142447

Asunto(s)

Inmunoterapia Adoptiva; Neoplasias; Humanos; Células Asesinas Naturales/metabolismo; Inmunoterapia; Neoplasias/terapia; Neoplasias/metabolismo; Linfocitos T

Palabras clave

biomanufacturing; bioreactor; natural killer cell; process analytical technology; quality by design; scale-up

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Neoplasias Límite: Humans Idioma: En Revista: Trends Biotechnol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google